Peptides modulating the activity of macrophages, useable for the treatment of rheumatoid arthritis
US9388226B2 · kind B2 · utility
0Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 3, 2007 |
| Grant date | Jul 12, 2016 |
| Priority date | — |
| Expiry date | Apr 15, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to citrulline peptides with anti-inflammatory properties. The invention also relates to an in vitro model for activation of macrophages, induced by immune complexes between specified IgG of rheumatoid arthritis and their citrulline targets.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.